Explore the history of generic drugs in the US, from the 1820 U.S. Pharmacopeia to the transformative Hatch-Waxman Act of 1984. Learn how regulations evolved to save the healthcare system trillions.
Landmark court decisions in generic patent law determine when affordable drugs reach the market. From Amgen v. Sanofi to Amarin v. Hikma, these rulings shape drug prices, patent strategies, and patient access.